Jiang W, Xiao D, Wu C, Yang J, Peng X, Chen L
Mol Ther Nucleic Acids. 2024; 35(3):102258.
PMID: 39045516
PMC: 11264179.
DOI: 10.1016/j.omtn.2024.102258.
Xia X, Zhu L, Xu M, Lei Z, Yu H, Li G
Mol Ther. 2024; 32(5):1561-1577.
PMID: 38454607
PMC: 11081937.
DOI: 10.1016/j.ymthe.2024.03.007.
Sadeghian I, Akbarpour M, Chafjiri F, Chafjiri P, Heidari R, Morowvat M
Naunyn Schmiedebergs Arch Pharmacol. 2023; 397(3):1275-1310.
PMID: 37688622
DOI: 10.1007/s00210-023-02683-3.
Abbasi W, Yaseen A, Hassan F, Andleeb S, Minhas F
BioData Min. 2020; 13(1):20.
PMID: 33292419
PMC: 7688004.
DOI: 10.1186/s13040-020-00231-w.
Chagula D, Rechcinski T, Rudnicka K, Chmiela M
Arch Med Sci. 2020; 16(4):715-726.
PMID: 32542072
PMC: 7286341.
DOI: 10.5114/aoms.2019.89836.
Brain Delivery and Brain Deposition of Proteins with Various Sizes.
Ulapane K, Kopec B, Siahaan T
Mol Pharm. 2019; 16(12):4878-4889.
PMID: 31664837
PMC: 8554818.
DOI: 10.1021/acs.molpharmaceut.9b00763.
New Mechanism for Release of Endosomal Contents: Osmotic Lysis via Nigericin-Mediated K/H Exchange.
Rangasamy L, Chelvam V, Kanduluru A, Srinivasarao M, Bandara N, You F
Bioconjug Chem. 2018; 29(4):1047-1059.
PMID: 29446616
PMC: 5926190.
DOI: 10.1021/acs.bioconjchem.7b00714.
Direct Macromolecular Drug Delivery to Cerebral Ischemia Area using Neutrophil-Mediated Nanoparticles.
Zhang C, Ling C, Pang L, Wang Q, Liu J, Wang B
Theranostics. 2017; 7(13):3260-3275.
PMID: 28900508
PMC: 5595130.
DOI: 10.7150/thno.19979.
Intracellular targeting with engineered proteins.
Miersch S, Sidhu S
F1000Res. 2016; 5.
PMID: 27547383
PMC: 4984483.
DOI: 10.12688/f1000research.8915.1.
Coaxial Electrospray of Ranibizumab-Loaded Microparticles for Sustained Release of Anti-VEGF Therapies.
Zhang L, Si T, Fischer A, Letson A, Yuan S, Roberts C
PLoS One. 2015; 10(8):e0135608.
PMID: 26273831
PMC: 4537102.
DOI: 10.1371/journal.pone.0135608.
Oncogenic protein interfaces: small molecules, big challenges.
Nero T, Morton C, Holien J, Wielens J, Parker M
Nat Rev Cancer. 2014; 14(4):248-62.
PMID: 24622521
DOI: 10.1038/nrc3690.
Rhizobium etli asparaginase II: an alternative for acute lymphoblastic leukemia (ALL) treatment.
Huerta-Saquero A, Evangelista-Martinez Z, Moreno-Enriquez A, Perez-Rueda E
Bioengineered. 2012; 4(1):30-6.
PMID: 22895060
PMC: 3566018.
DOI: 10.4161/bioe.21710.
Bacterial Magnetosome: A Novel Biogenetic Magnetic Targeted Drug Carrier with Potential Multifunctions.
Sun J, Li Y, Liang X, Wang P
J Nanomater. 2012; 2011(2011):469031-469043.
PMID: 22448162
PMC: 3310401.
DOI: 10.1155/2011/469031.
Biodistribution mechanisms of therapeutic monoclonal antibodies in health and disease.
Tabrizi M, Bornstein G, Suria H
AAPS J. 2009; 12(1):33-43.
PMID: 19924542
PMC: 2811642.
DOI: 10.1208/s12248-009-9157-5.
